ArmaVir Partners makes direct equity investments in operating companies and unique assets.
Business Model:
Revenue: $0
Employees: 0-0
Address: 40 West 57th Street
City: New York
State: NY
Zip: 10019
Country: US
ArmaVir Partners, formerly the Ramius Private Investments Group makes direct equity investments in operating companies and unique assets. It takes an active approach and makes control or significant minority investments in small-to-mid-sized operating companies. It also looks to make minority investments in select high growth private companies. In 2018, Armavir Partners spun out of its former parent, Cowen Inc. ArmaVir Partners has over $300 million in assets under management. ArmaVir Partners is actively seeking new investment opportunities in North America and Western Europe. Typically it looks to invest $10-100+ million. The firm is generalists, with significant experience in telecommunications, consumer products, industrials, financial services, and renewable energy.
Contact Phone:
+16465621151
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2019 | NJOY | Private Equity Round | 0 |
8/2005 | BravoSolution | Venture Round | 0 |
4/2019 | PAX Labs | Venture Round | 0 |
8/2009 | CEL-SCI | Post-IPO Equity | 0 |
2/2000 | ci4net.com | Venture Round | 0 |
1/2020 | CALDER GROUP | Private Equity Round | - |
9/2010 | Cascadian Therapeutics | Post-IPO Equity | 0 |
7/2012 | Bluebird Bio | Series D | 0 |
3/2000 | EarlyBirdCapital | Venture Round | 11M |
2/2010 | SinoHub | Venture Round | 4.6M |
5/2019 | NJOY | Private Equity Round | 0 |
3/2010 | Biomoda | Venture Round | 0 |
1/2000 | Xceed Software | Private Equity Round | 30M |
1/2020 | CALDER GROUP | Private Equity Round | - |
5/2019 | NJOY | Private Equity Round | 0 |
4/2019 | PAX Labs | Venture Round | 0 |
1/2019 | NJOY | Private Equity Round | 0 |
7/2012 | Bluebird Bio | Series D | 0 |
9/2010 | Cascadian Therapeutics | Post-IPO Equity | 0 |
3/2010 | Biomoda | Venture Round | 0 |
2/2010 | SinoHub | Venture Round | 0 |
8/2009 | CEL-SCI | Post-IPO Equity | 0 |
8/2005 | BravoSolution | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|